StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · PYPD·Healthcare

PolyPid Ltd. Stock Analysis & AI Score

PolyPid Ltd. (PYPD) has an ST Score of 49.7 (C+), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $12.50 price target (+133.2% upside).

Market Closed
$5.36
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
50
ST Score
49.7/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

PYPD
49.7out of 100
Grade C+

PolyPid Ltd. (PYPD) has an ST Score of 49.7 (C+), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $12.50 price target (+133.2% upside).

Strongest
ForecastA
Weakest
Financial StrengthD-
All factor grades
  • ForecastA
  • MomentumA-
  • GrowthA-
  • ValuationB-
  • ProfitabilityC-
  • Financial StrengthD-
  • Piotroski1/9
Score methodology
Press Releases

Contact

PYPD stock: frequently asked questions

What is PYPD's ST Score?

PolyPid Ltd. (PYPD) has an ST Score of 49.7 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is PYPD a buy, hold, or sell?

Analysts rate PYPD a Buy, with a price target of $12.50 (+133.2% vs the current price). Our ST Score grades it C+ (49.7/100). The ST Score is a data-driven signal, not a recommendation.

What are PYPD's factor grades?

Valuation B-, Profitability C-, Financial Strength D-, Momentum A-, Growth A-, Forecast A.

What is PYPD's valuation grade?

PolyPid Ltd. (PYPD) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is PYPD's growth grade?

PolyPid Ltd. (PYPD) earns a growth grade of A-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is PYPD's profitability grade?

PolyPid Ltd. (PYPD) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is PYPD's financial strength grade?

PolyPid Ltd. (PYPD) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for PYPD?

The average analyst price target for PolyPid Ltd. (PYPD) is $12.50 from 9 analysts, which is +133.2% versus the recent price of $5.36.

What is PYPD's Piotroski score?

PolyPid Ltd. (PYPD) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.